SUMMIT, N.J. — June 24, 2025 — Kenvue Inc. (NYSE: KVUE) today announced the appointment of Anindya (Andy) Dasgupta as the Company’s Group President, Asia Pacific, effective July 14, 2025. Mr. Dasgupta will join Kenvue to lead the Asia Pacific region, which contributed approximately $3 billion in Net sales in fiscal year 2024, into the company’s next chapter of accelerated growth. Following a thorough and thoughtful search process, Mr. Dasgupta will succeed Ellie Xie, who will remain with the Company for a brief period to help ensure a smooth transition.
With nearly 30 years of experience with consumer products organizations, including GSK, PepsiCo, Fonterra and Imperial Brands, Mr. Dasgupta’s brand-building experience includes leadership roles in health, nutrition and food and beverage sectors across emerging and developed markets. He has held C-suite-level roles for more than eight years and senior-level regional and global positions across Europe, the US and Asia Pacific, and founded and operated Growth Officers Inc. Pvt. Ltd, a consulting firm helping private equity portfolio companies identify acquisition targets and execute plans against key business growth levers.
“Andy is a transformational commercial business leader with a strong track record of driving growth and delivering value,” said Thibaut Mongon, Chief Executive Officer, Kenvue. “He brings proven expertise in commercial strategy, sales, marketing and business development. We are excited to welcome him to our leadership team and look forward to his results-driven leadership across our Asia Pacific region.”
Mr. Mongon added, “I would like to thank Ellie for her contributions to Kenvue.She was instrumental in establishing our standalone company in the region, reshaping our Asia Pacific portfolio to reflect Kenvue’s strengths, and significantly upgrading our digital commercial capabilities, scaling a new social and ecommerce model across all markets in the region. We wish her all the best.”
About Mr. Dasgupta
Anindya (Andy) Dasgupta will be Group President, Asia Pacific, for Kenvue. He will lead a fully integrated, end-to-end team, responsible for driving the company’s growth strategy in the Asia-Pacific region and capitalizing on the rapid acceleration of markets, data, technology and science to achieve superior consumer experiences.
Andy is a transformational commercial business leader, with nearly 30 years of experience with consumer product organizations and particular expertise in commercial strategy, business development, sales and marketing. Prior to joining Kenvue, Andy served as Chief Consumer Officer for Imperial Brands, where he helped lead the company’s product portfolio transformation by overseeing the creation of the company’s new non-tobacco business stream.
Prior to Imperial Brands, Andy served in senior leadership roles in other global consumer products companies such as Fonterra, PepsiCo and GSK, holding regional and global positions across Europe, the U.S. and Asia. At Fonterra, he served as Global Head, Consumer Business and Chief Marketing and Sales Officer after having previously held the role of Global Chief Marketing Officer. Within four-and-a-half years, he grew Fonterra’s consumer dairy business from $1.1 billion to $3.2 billion with full P&L responsibility. Andy’s nine years at PepsiCo culminated in his role as Global Senior Director, Beverages, in which he led the company’s $32 billion non-carbonated business globally from a brand and portfolio perspective. At GSK, he held various positions within the company’s consumer goods division in India and the UK.Andy is also the founder of Growth Officers Inc. Pvt. Ltd, a consulting firm helping private equity portfolio companies across South East Asia, Africa and Europe identify acquisition targets and execute plans against key business growth levers.
Andy holds a bachelor’s degree in economics and statistics from Jadavpur University and a post graduate degree in management from the Indian Institute of Management, Calcutta.
About Kenvue
Kenvue Inc. is the world’s largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson’s®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we realize the extraordinary power of everyday care. Our teams work every day to put that power in consumers’ hands and earn a place in their hearts and homes. Learn more at www.kenvue.com.
Cautions Concerning Forward-Looking Statements
This media alert contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regarding Kenvue’s Group President, Asia Pacific, transition. Forward-looking statements may be identified by the use of words such as “plans,” “expects,” “will,” “anticipates,” “estimates” and other words of similar meaning. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Kenvueand its affiliates.
A list and descriptions of risks, uncertainties and other factors can be found in Kenvue’s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended December 29, 2024 and subsequent Quarterly Reports on Form 10-Q and other filings, available at www.kenvue.com or on request from Kenvue. Kenvue and its affiliates undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or developments or otherwise.